The highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact.
Pinney JJ, Blick-Nitko SK, Baran AM, Peterson DR, Whitehead HE, Izumi R, Munugalavadla V, Van DerMeid KR, Barr PM, Zent CS, Elliott MR, Chu CC.
Pinney JJ, et al. Among authors: elliott mr.
Haematologica. 2022 Jun 1;107(6):1460-1465. doi: 10.3324/haematol.2021.279560.
Haematologica. 2022.
PMID: 35172559
Free PMC article.
No abstract available.